The Need for COVID-19 Research
Scientists are still learning about COVID-19 and how long immunity from previous infection and/or vaccination can last. Velocity has enrolled more than 12,000 patients in COVID-19 trials since research efforts began in early 2020, and continues to enroll participants for research studies of:
- Medications intended to reduce the severity of COVID-19
- Vaccines intended to prevent COVID-19 infection
- Diagnostics intended to detect COVID-19 infection and/or antibodies
How to Participate in a COVID-19 Medication Clinical Trial
Velocity has research sites nationwide that are conducting clinical trials in a wide range of therapeutic areas. New studies are added every week. You can help fight COVID-19 by joining a clinical trial at Velocity.
Beyond helping advance medicine, you may also:
- Learn about potential new medicines in development
- Get study-related medical exams at no cost
- Receive compensation for participating (available amounts may differ for each study)
The best way to find out which COVID-19 research studies are currently enrolling patients in your community and determine your eligibility is to complete the form on this page or call Velocity to speak with an enrollment specialist.
After you submit your information, a Velocity enrollment specialist will contact you. Together, we’ll review studies that might be right for you and answer your questions.
Health insurance is NOT required to join. There is never an obligation to participate — we’re here to help you make the best decision.
For more information about currently enrolling COVID-19 clinical trials, complete the form on this page or select a location below to get in touch with a Velocity enrollment specialist.
